Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Future placebo-controlled trials of disease modifying therapy in relapsing multiple sclerosis would be unethical: Yes.
An oral NaV1.8 blocker improves motor function in mice completely deficient of myelin protein P0.
A Systematic Review of Health-related Work Outcome Measures, and Quality Criteria based Evaluations of their Psychometric Properties.
Pathophysiological significance of the two-pore domain K(+) channel K2P5.1 in splenic CD4(+)CD25(-) T cell subset from a chemically-induced murine inflammatory bowel disease model.
Depletion of CD4+ CD25+ regulatory T cells confers susceptibility to experimental autoimmune encephalomyelitis (EAE) in GM-CSF-deficient Csf2-/- mice.
MRI in the evaluation of pediatric multiple sclerosis.
Leukodystrophies.
The relationship between sleep quality and perceived fatigue measured using the Neurological Fatigue Index in people with Multiple Sclerosis.
Blood-Spinal Cord Barrier Alterations in Subacute and Chronic Stages of a Rat Model of Focal Cerebral Ischemia.
Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis.
CDR3 sequence preference of TCRBV8S2+ T cells within the CNS does not reflect single amino acid dependent avidity expansion.
Prevalence of multiple sclerosis in Iranian emigrants: review of the evidence.
Challenge of phenotype estimation for optimal treatment of Krabbe disease.
Formation and disruption of functional domains in myelinated CNS axons.
Immunomodulation of inflammatory leukocyte markers during intravenous immunoglobulin treatment associated with clinical efficacy in chronic inflammatory demyelinating polyradiculoneuropathy.
Retinal Vascular Fractals Correlate With Early Neurodegeneration in Patients With Type 2 Diabetes Mellitus.
Safety and T cell modulating effects of high dose vitamin D3 supplementation in multiple sclerosis.
Mesenchymal Stromal/Stem Cells Do Not Ameliorate Experimental Autoimmune Encephalomyelitis and Are Not Detectable in the Central Nervous System of Transplanted Mice.
Corrigendum.
Evaluation of species difference in peripheral lymphocyte reduction effect by CS-0777, a sphingosine 1-phosphate receptor modulator, based on a pharmacokinetic/pharmacodynamic model analysis.
Follow-up of hypertension in patients with multiple sclerosis.
Vitamin D Intake and its Protective Role in Multiple Sclerosis: The Checkmate to Survivin?
Economic Impact of Integrated Care Models for Patients with Chronic Diseases: A Systematic Review.
Neuromyelitis optica relapses: Race and rate, immunosuppression and impairment.
Psychosocial difficulties of individuals with multiple sclerosis: the PARADISE-24 questionnaire.
Pages
« first
‹ previous
…
730
731
732
733
734
735
736
737
738
…
next ›
last »